proteins. Receptor-activated Smads associate with the common
The effects of TGFβ on cell growth are cell-type-dependent.
Transforming growth factor-β1 (TGFβ) is involved in the
While TGFβ exerts growth stimulatory activity on certain cells regulation of liver cell proliferation and apoptosis, and of mesenchymal origin, proliferation of many epithelial cells escape of hepatoma cells from the growth restraining is inhibited (1,2). The growth inhibitory effects of TGFβ take signals of TGFβ has been suggested to contribute to place at the G 1 phase of the cell cycle, e.g. through negative tumor development. TGFβ modulates gene transcription regulation of Rb, c-myc or cyclin-dependent kinases (Cdks), by receptor-mediated activation of Smad proteins which act such as Cdk4, or stimulation and activation of Cdk inhibitors, as transcription factors. TGFβ-mediated primary signaling such as p27 Kip1 , p15 Ink4B , or p21 Cip1/Waf1 (2,7). In addition to responses as well as effects on the cell cycle and apoptosis its growth inhibitory effects, TGFβ has been shown to induce were investigated in the human hepatoblastoma line apoptosis in certain cell types, including hepatocytes. Although HepG2, the rat hepatoma line FTO-2B and the mouse induction of apoptosis by TGFβ is less well studied than cell hepatoma line 55.1c. Activation of a Smad (Sma and Mad growth arrest, TGFβ is known as an important physiological homolog) response-element-driven luciferase reporter by mediator of liver cell apoptosis both in vivo and in vitro (reviewed in 8,9).
TGFβ was very similar in all three cell lines, indicating
Because of the important role of TGFβ in regulation of functionality of the primary TGFβ signaling pathway.
fundamental cell homeostatic processes, it is not surprising Moreover, TGFβ-inducible early gene was transiently activthat many tumor cells of different origin are either partially ated by TGFβ in all cell lines as shown by RT-PCR. HepG2 or completely resistant to the anti-proliferative effects of TGFβ cells, however, were completely resistant to TGFβ-induced (10, 11) . This lack of responsiveness may result from mutational growth arrest and apoptosis and 55.1c cells were only inactivation or downregulation of the TGFβ receptor system slightly susceptible to TGFβ-induced apoptosis. By contrast, or from defects in downstream effectors (6,10,12). During treatment of FTO-2B cells with TGFβ led to a partial hepatocarcinogenesis, dysregulation of the TGFβ signaling G 0 /G 1 arrest and a strong induction of apoptosis. TGFβ-pathway has been shown to occur at several levels. Activation induced apoptosis of FTO-2B cells was inhibited by of the latent TGFβ complex to the mature cytokine can be dexamethasone, insulin, phenobarbital and dieldrin. Of impaired either by inactivation of the M6P/IGF2 receptor these agents, only insulin led to a significant reduction of through mutations and loss of heterozygosity in human hepato-TGFβ-stimulated Smad-reporter activity, suggesting that cellular carcinomas (13) or by downregulation of this receptor the other compounds interfere with TGFβ-induced during hepatocarcinogenesis in both humans and rats (14,15). apoptosis downstream of Smad-mediated primary tranSimilarly, reduced expression of the TGFβ type II receptor scriptional responses at a level that may be constitutively has been observed in human and rat liver tumors (15-18). altered in apoptosis-resistant hepatoma cell lines.
Although mutations in Smad genes and functional alterations of Smad proteins have been described in cancers of several organs (6,12), only circumstantial evidence on disruption of Introduction Smad signaling in hepatocellular tumors is available (9). Transforming growth factor-β1 (TGFβ) is the prototype of a
We have now comparatively analyzed the effects of TGFβ family of cytokines that are involved in regulation of various on Smad activation and related primary signaling responses in cellular responses including cell growth, differentiation and FTO-2B cells, a rat hepatoma line which is responsive to apoptosis (1,2). TGFβ is synthesized and secreted as a latent induction of apoptosis by TGFβ (19) , and in HepG2 cells, precursor and becomes activated via a complex proteolytic a human hepatoblastoma line which is resistant to TGFβ-process that requires interaction with the mannose-6-phosphate/ mediated apoptosis and cell cycle arrest (20) (21) (22) (23) , as well as in the mouse hepatoma cell line 55.1c (24). In addition, insulin-like growth factor-II (M6P/IGF2) receptor (3). Mature alterations in Smad signaling were studied under conditions TGFβ binds to its high-affinity cell surface receptor consisting known to interfere with TGFβ-induced apoptosis in FTO-2B cells (19) . 4 and pRL-CMV a 100ϫ stock was used. Phenobarbital was obtained from Geyer (Renningen, plasmids were incubated with 5 ng/ml TGFβ or solvent for 8 (FTO-2B) or Germany) and dieldrin, dexamethasone, and insulin from Sigma (München, 24 h (HepG2 and 55.1c). Luciferase activities were determined by the dualGermany). TGFβ/solvent controls were incubated with TGFβ and the solvent luciferase system as described in Materials and methods. Fold induction of of the respective apoptosis inhibitor. In some experiments cells were irradiated reporter activity by TGFβ (means ϩ SD) from three to five experiments, with UV light (200 J/m 2 ) using a DNA-crosslinker (Biometra, Göttingen, each consisting of six independent transfections per treatment, is shown Germany).
(*P Ͻ 0.05, ** P Ͻ 0.01; Student's t-test). Apoptosis was quantitated by determination of caspase-3-like activity as described previously (19) using N-acetyl-Asp-Glu-Val-Asp-amino-trifluoromethyl-coumarin (DEVD-AFC, Biomol, Hamburg, Germany) as a substrate.
rounds using recombinant Taq DNA polymerase (MBI Fermentas, Flow cytometric analyses were performed essentially according to Nicoletti
St Leon-Roth, Germany); denaturing (94°C), annealing (60°C) and primer et al. (25) . In brief, cells were detached from the culture dishes by Trypsin/ extention (72°C) were for 1 min each (UNO-thermocycler, Biometra). During EDTA treatment, washed with PBS and incubated with propidium iodide the last 18 rounds additional primers for co-amplification of a 232 bp fragment [50 µg/ml in 0.1% (w/v) sodium citrate/0.1% (v/v) Triton X-100] for of β-actin were added. Control reactions without RNA and reverse transcriptase 5 min. Propidium iodide fluorescence was measured on the FACS Calibur were consistently negative. The following primers were used: TIEG1-F cytofluorometer (Becton Dickinson) and cell cycle distribution, as well as 5Ј-CAGCCAACCATGCTCAACTTCG-3Ј; TIEG1-R 5Ј-TTGAGGATGCTGsubdiploid (apoptotic) nuclei, were quantitated using CellQuest 3.0.1.f and GCTGCTTTCA-3Ј; β-actin-F 5Ј-ATGAAGTGTGACGTTGACATCCG-3Ј ModFit LT V2.0 software. and β-actin-R 5Ј-GCTTGCTGATCCACATCTGCTG-3Ј. Both primer pairs were intron-spanning to exclude interference with amplification from genomic Transfection experiments and reporter assays DNA. PCR products were separated on 10% polyacrylamide gels, stained FTO-2B, HepG2 and 55.1c cells were plated on 24-well plates (1-2ϫ10 5 with ethidium bromide, photographed and quantitated by image analysis cells/well) and transfected with 1-2 µg/well of the pGL3ti(SBE) 4 reporter (equipment as above). β-Actin signals were used for normalization of plasmid (kindly provided by Dr W.Kruijer, Haren, The Netherlands) using TIEG1 signals. Unifectin-M (kindly provided by Dr A.Surovoy, Tübingen, Germany). This
Statistical analysis plasmid contains four copies of the Smad binding element (SBE) driving Student's t-test was performed using Microsoft® Excel 97 SR-1. the Firefly luciferase reporter gene (26) . Cells were co-transfected with 5-10 ng/well of the Renilla luciferase reporter plasmid pRL-CMV (Promega, Mannheim, Germany) which was used for normalization of transfection system and display similar primary TGFβ responses.
and quantitated by image analysis (TINA V2.09g, Raytest).
To study the biological consequences of Smad activation, TIEG mRNA expression analyses the effects of TGFβ on cell cycling and apoptosis were Expression of TIEG1 mRNA was analyzed by reverse transcription-polyanalyzed in FTO-2B and HepG2 cells. While TGFβ led to a merase chain reaction (RT-PCR) essentially as described previously (27) .
slight, but significant cell-cycle arrest in FTO-2B cells, as HepG2 cells, whereas the inverse situation was found with respect to the anti-apoptotic protein Bcl-x L (Figure 4) . Expression levels of the pro-apoptotic protein Bax were similar in two cell lines were also obtained with respect to TGFβ-induced apoptosis, which was analyzed by determination of caspaseall three cell lines. Induction of apoptosis by TGFβ may be mediated by 3-like activity (Figure 3) . Treatment of FTO-2B cells with TGFβ for 24 h led to an~16-fold increase in caspase-3-like transcriptional activation of the TGFβ-inducible early gene (TIEG). We therefore comparatively analyzed the effects of activity over untreated controls, indicating a strong apoptotic response in this cell line. Similar results were obtained by TGFβ on TIEG1 expression by RT-PCR in FTO-2B, HepG2 and 55.1c cells. Since human TIEG1 is transcribed from the cytofluorometric analysis of subdiploid apoptotic nuclei (see Figure 6 ). HepG2 cells, in contrast, did not show any increase same gene as early growth response α (EGRα) (28), one of the primers used for PCR (TIEG1-F) was designed for exon in caspase-3-like activity upon TGFβ treatment for 24 h ( Figure  3) . Analyses for up to 48 h after TGFβ application also 1a which is not shared by EGRα and is therefore specific for TIEG1. Alternative transcripts have also been reported for revealed no signs of apoptosis (data not shown), demonstrating that HepG2 cells are resistant to TGFβ-induced apoptosis, mouse TIEG (29) . As shown in Figure 5 , TGFβ led to a transient induction of TIEG1 in all three cell lines with a which is in accordance with findings of others (20, 21) . HepG2 cells, however, do not show a general defect in apoptotic maximum at 1 h of TGFβ treatment. The level of induction in the apoptosis-resistant HepG2 cell line was comparable response, since the use of UV irradiation as a trigger of apoptosis led to a sharp increase in caspase-3-like activity with that observed in the apoptosis sensitive FTO-2B cells, indicating that TIEG1 is not responsible for the differences in (Figure 3 ) and appearance of apoptotic cells (data not shown). Similarly, 55.1c cells are almost completely resistant to TGFβ-apoptotic response of the hepatoma cell lines tested.
We have previously shown that apoptosis of FTO-2B cells induced apoptosis (Figure 3 ), but show a strong apoptotic response after UV irradiation (27) .
can be inhibited by a variety of endogenous and exogenous compounds, such as dexamethasone, insulin, phenobarbital or The difference between FTO-2B, HepG2 and 55.1c cells in their response to TGFβ could be due to differences in the dieldrin (19) . Confirming our previous observations, TGFβ-induced apoptosis was reduced by 50-80% when FTO-2B expression of cell-cycle and apoptosis-associated proteins. In various cell lines, TGFβ-induced cell-cycle arrest has been cells were treated simultaneously with TGFβ and either of these inhibitors (Figure 6 ). Since suppression of apoptosis by shown to be associated with transcriptional activation of inhibitors of Cdks (7). Analysis of two representative candidthe above agents could result from an interference with that cells derived from hepatocellular tumors and even preneoplastic hepatocytes are resistant to the growth inhibitory effects TGFβ/Smad signaling, the effects of dexamethasone, insulin, of TGFβ (e.g. 22, 23, [30] [31] [32] . Similarly, resistance of hepatoma phenobarbital and dieldrin on the activity of the pGL3ti-(SBE) 4 cells to TGFβ-induced apoptosis has been reported (20, 21) . luciferase reporter were investigated. Reporter activity was Alterations in function and expression of TGFβ-associated determined in transiently transfected FTO-2B cells after simulreceptors have been shown to contribute to the aberrant TGFβ-taneous treatment with TGFβ and the inhibitors for 8 h. While response of hepatoma cells (9); however, comparatively little insulin reduced TGFβ-induced reporter gene activity by~50% is known about qualitative or quantitative alterations in downcompared with controls treated with TGFβ alone, no significant stream effectors within the TGFβ pathway. effects on reporter activity were obtained with dexamethasone,
To gain an insight into the role of Smad proteins for phenobarbital or dieldrin (Figure 7) . regulation of cell cycling and apoptosis in hepatoma cells, we were interested in two questions: (i) do cell lines either Discussion responsive or refractory to TGFβ-induced growth arrest and apoptosis show differences in Smad-mediated transcriptional TGFβ is an important physiological mediator of cell homeostasis in liver and escape of tumor cells from the growth responses to TGFβ, and (ii) how is the primary TGFβ signaling pathway affected by compounds known to inhibit TGFβ-and failed to suppress Smad-mediated transcriptional reponses in FTO-2B cells (this paper (20) (21) (22) (23) , cannot be due to defects in TGFβ-associated receptor point of interference is unknown but does not appear to be related to cell-cycle control since cell-cycle distribution of systems, since they are known to possess TGFβ type I and II receptors (33) and respond to TGFβ with functional Smad FTO-2B cells was not significantly affected by the above mentioned agents (data not shown); only dexamethasone led signaling (26, 34, 35 possibility of interference with early TGFβ signaling events 13. De Souza,A.T., Hankins,G.R., Washington,M.K., Orton,T.C. and Jirtle,R.L. (19) . Our present results demonstrate that phenobarbital, diel- apoptosis inhibitors studied, which do not activate Erk1/2 (19) 
